Guillaume Hautbergue - Free People Check with News, Pictures & Links

	Sheffield

	University of Sheffield RNA Department United Kingdom

Images of Guillaume Hautbergue

(0 from 0 )

News

New gene therapy treatment routes for motor neurone disease uncovered...

www.medica-tradefair.com

... up new areas of investigation for gene therapy," explains University of Sheffield's Dr Guillaume Hautbergue, who conceived the study and led ...

Oxford Autumn School in Neuroscience | Events | The British...

www.bna.org.uk

Network Profiles

LinkedIn: Guillaume Hautbergue | Professional Profile - LinkedIn

View Guillaume Hautbergue's professional profile on LinkedIn. LinkedIn is the world's largest business network, helping professionals like Guillaume ...

Loop | Guillaume Marcel Hautbergue

loop.frontiersin.org

Guillaume Marcel Hautbergue. Doctorate. University of Sheffield. Sheffield, United Kingdom. Primary. View All. mini profile avatar Guillaume Hautbergue.

Business Profiles

Researchgate: Guillaume Hautbergue

Sheffield, South Yorkshire, United Kingdom

Employees

Dr Guillaume Hautbergue | Medical School | The University of Sheffield

www.sheffield.ac.uk

Dr Guillaume Hautbergue MSc PhD Lecturer in Translational Neuroscience Head of RNA Biology Laboratory. Department of Neuroscience Sheffield Institute of Translational

Education

Sheffield Motor Neurone Disease Research Advisory Group | 2016

smndrag.group.shef.ac.uk

Dr Guillaume Hautbergue gave an interesting overview on the gene therapy project his team are currently working on. We look forward to further updates on the ...

Books & Literature

PLOS ONE: C9ORF72 GGGGCC Expanded Repeats Produce Splicing...

journals.plos.org

Guillaume Hautbergue,. Affiliation Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, 385A Glossop Road, ...

Publications

The Yeast C-Type Cyclin Ctk2p Is Phosphorylated and Rapidly Degraded...

core.ac.uk

The Yeast C-Type Cyclin Ctk2p Is Phosphorylated and Rapidly Degraded by the Ubiquitin-Proteasome Pathway . By Guillaume Hautbergue and Valérie Goguel. Abstract.

Publications Authored by Pamela J Shaw | PubFacts

www.pubfacts.com

Publications Authored by Pamela J Shaw

theses.fr – GUILLAUME HAUTBERGUE , Fonction(s) du complexe ctd kinase...

www.theses.fr

Fonction(s) du complexe ctd kinase i de s. Cerevisiae et analyse du mecanisme atypique de regulation de son activite par GUILLAUME HAUTBERGUE

Miscellaneous

Cognitive Neuroscience Forum - Scientists and non-scientists ...

groups.yahoo.com

... Matthew Wyles, Adrian Higginbottom, Catherine Gelsthorpe, J. Robin Highley, Guillaume Hautbergue, Magnus Rattray, Janine Kirby, Pamela ...

Hautbergue Guillaume - Recherche de personnes | Trombi

www.trombi.com

1 résultats pour Hautbergue Guillaume à . Sur Trombi.com, vos recherches sont gratuites.

DiMeN Doctoral Training Partnership: Investigating the role of RNA...

www.findaphd.com

PhD Project - DiMeN Doctoral Training Partnership: Investigating the role of RNA exporter GLE1 in motor neuron diseases at University of Sheffield, listed on...

GGGGCC Repeat Expansion of C9ORF72 Is Toxic Via Sequestration Of RNA...

n.neurology.org

Guillaume Hautbergue 5, 6 and Pamela Shaw 3; 1 Turkey 2 Sheffield United Kingdom 3 The University of Sheffield Sheffield United Kingdom 4

E-GEOD < Browse < ArrayExpress < EMBL-EBI

www.ebi.ac.uk

EMBL-EBI

Assignment of H, C, and N resonances for the REF2-I mRNA export factor

www.infona.pl

... Faculty of Life Sciences, Manchester, UK. Guillaume Hautbergue. University of Sheffield, Department of Molecular Biology and Biotechnology, Sheffield, UK ...

Découverte du premier facteur létal de Burkholderia pseudomallei, BLF1

www.ipubli.inserm.fr

Une avancée majeure pour contrer la mélioïdose. Guillaume Hautbergue. Department of molecular biology and biotechnology, the university of ...

E-GEOD < Browse < ArrayExpress < EMBL-EBI

www.ebi.ac.uk

EMBL-EBI

médecine/sciences

www.medecinesciences.org

Article cité: Découverte du premier facteur létal de Burkholderia pseudomallei, BLF1 - Une avancée majeure pour contrer la mélioïdose. Guillaume Hautbergue.